Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5197076 | 0.93 | DUT (0.31) | DUT | |
| SCHEMBL7245930 | 0.90 | ALDH1A1 (0.34) | DUTALDH1A1 | |
| SCHEMBL7245925 | 0.90 | ALDH1A1 (0.34) | DUTALDH1A1 | |
| SCHEMBL7978233 | 0.90 | ALDH1A1 (0.34) | DUTALDH1A1 | |
| SCHEMBL27131148 | 0.83 | DUT (0.32) | DUT | |
| SCHEMBL27032052 | 0.83 | DUT (0.32) | DUT | |
| SCHEMBL14212533 | 0.81 | DUT (0.33) | DUT | |
| SCHEMBL2888135 | 0.80 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL13135988 | 0.80 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL2888132 | 0.80 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365585-A1 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | PFIZER INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230365585-A1 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | PFIZER INC. | 2023-11-16 | — | — | US | disclosed |
| US-20080318878-A1 | Antibacterial Agents | RANBAXY LABORATRIES LIMITED (IN) | 2008-12-25 | — | — | US | disclosed |
| EP-1812455-A2 | ERYTHROMYCIN A DERIVATIVES AS ANTIBACTERIAL AGENTS | Ranbaxy Laboratories Limited (IN) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006035301-A2 | ERYTHROMYCIN A DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365585-A1 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | CNR1, SIGMAR1, CBR1 | DUT 4741/4885ALDH1A1 2494/4885 |
| US-20080318878-A1 | Antibacterial Agents | MLX, MGAM, CAT | DUT 3176/4885ALDH1A1 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.